Radiation to abdominal nerves for pancreatic cancer pain
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests whether focused radiation on nerves in the abdomen can reduce pain from advanced pancreatic cancer. If you join, you'll receive this treatment and your pain levels will be monitored.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pancreatic cancer that has spread and cannot be removed with surgery.
- You have abdominal pain that is not relieved enough by current painkillers.
- You are at least 18 years old.
- You have had a CT scan within the last 2 months.
- If you are on chemotherapy, you can take a break from it for at least 7 days before and after the radiation treatment.
- You have not had radiation therapy to your abdomen before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a type of radiation therapy (SBRT) to treat severe stomach pain caused by cancer pressing on nerves near the stomach. It aims to provide pain relief without the need for a standard nerve block procedure.
This trial tests a focused radiation treatment called stereotactic body radiotherapy (SBRT) to target pain from cancer affecting the celiac plexus—a bundle of nerves in the upper abdomen. The goal is to relieve severe, persistent pain without surgery.
This trial tests a way to give radiation therapy for pancreatic cancer using MRI scans to guide the treatment. It aims to make the radiation more precise and possibly more effective, and you will receive chemotherapy first, followed by radiation.
This trial tests a precise type of radiation therapy guided by MRI for people with locally advanced pancreatic cancer. It aims to treat the tumor while protecting nearby healthy tissue, potentially improving outcomes after chemotherapy.
This trial tests a combination of targeted radiation and two oral drugs (defactinib and avutometinib) for people with advanced pancreatic cancer that hasn't spread to distant organs. It may be an option if you've already had at least 2 months of chemo and your cancer is still locally advanced or borderline resectable.
This trial tests a new treatment that uses tiny alpha radiation sources placed directly into the tumor to destroy cancer cells. It is for people with pancreatic cancer that has not spread but cannot be removed surgically, and who have already tried at least one type of chemotherapy or cannot take more chemo.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.